Tirzepatide, a dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in some studies, with weight reductions of approximately 20% in the SURMOUNT-1 trial
Mounjaro and Ozempic are designed to be taken long-termand sometimes indefinitelyto maintain blood sugar and weight loss results
Patients can visit Ro.co to access the KwikPen along with ongoing high-quality clinical care, including 24/7 messaging, 1-1 coaching, educational content, weight tracking and dose logging, side-effect monitoring, and more
GLP-1 in the brain stem is activated due to stress and causes a loss of appetite
Some studies also noted slightly increased heart rate during titration, which settled over time
Each pill contains 3mg Retatrutide and is designed for simple once-daily use within the intended research framework